A Prospective Observational Study to Assess the Efficacy of a SGLT2 Inhibitor (Dapagliflozin) in Kidney Allograft Recipients with Diabetes Mellitus

被引：0
|
作者：
Naskar, Avishek [1 ]
机构：
[1] Kolkata Kidney Inst, Kolkata, West Bengal, India
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024ej3cxwcq
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO741
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Dapagliflozin, an SGLT2 inhibitor, for diabetes
    Hanefeld, Markolf
    Forst, Thomas
    LANCET, 2010, 375 (9733): : 2196 - 2198
  • [2] Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus
    Paola Fioretto
    Andrea Giaccari
    Giorgio Sesti
    Cardiovascular Diabetology, 14
  • [3] Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus
    Fioretto, Paola
    Giaccari, Andrea
    Sesti, Giorgio
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [4] THE SGLT2 INHIBITOR DAPAGLIFLOZIN IMPROVES ERECTILE DYSFUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A PROSPECTIVE STUDY
    Cannarella, Rossella
    Condorelli, Rosita A. Angela
    Leanza, Claudia
    Garofalo, Vincenzo
    Lundy, Scott
    Calogero, Aldo E.
    La Vignera, Sandro
    FERTILITY AND STERILITY, 2023, 120 (04) : E245 - E246
  • [5] RE: The Efficacy and Safety of SGLT2 Inhibitor in Kidney Transplant Recipients With Diabetes
    Lim, Jeong-Hoon
    Cho, Jang-Hee
    TRANSPLANTATION, 2023, 107 (03) : E80 - E81
  • [6] The Efficacy and Safety of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients
    Lim, Jeong-Hoon
    Kwon, Soie
    Jeon, Yena
    Kim, Young Hoon
    Kwon, Hyunwook
    Kim, Yon Su
    Lee, Hajeong
    Kim, Yong-Lim
    Kim, Chan-Duck
    Park, Sun-Hee
    Lee, Jong Soo
    Yoo, Kyung Don
    Son, Hyung Eun
    Jeong, Jong Cheol
    Lee, Jeonghwan
    Lee, Jung Pyo
    Cho, Jang-Hee
    TRANSPLANTATION, 2022, 106 (09) : E404 - E412
  • [7] Safety and efficacy of the SGLT2 inhibitor dapagliflozin in older patients with type 2 diabetes
    Fioretto, P.
    de Bruin, T. W.
    Johnsson, E.
    Ptaszynska, A.
    Parikh, S.
    List, J. F.
    DIABETOLOGIA, 2013, 56 : S383 - S383
  • [8] DAPAGLIFLOZIN, AN SGLT2 INHIBITOR FOR THE TREATMENT OF TYPE 2 DIABETES
    Demaris, K. M.
    White, J. R.
    DRUGS OF TODAY, 2013, 49 (05) : 289 - 301
  • [9] SGLT2 INHIBITION IN KIDNEY TRANSPLANT RECIPIENTS WITH DIABETES
    Guthoff, M.
    Mahling, M.
    Nadalin, S.
    Heyne, N.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 32 - 32
  • [10] SGLT2 inhibitor dapagliflozin lowers risk of heart failure in diabetes
    Overbeck P.
    MMW - Fortschritte der Medizin, 2018, 160 (20) : 18 - 19
12345